share_log

Bank of America Corp DE Decreases Stock Holdings in LivaNova PLC (NASDAQ:LIVN)

Defense World ·  Sep 28, 2022 04:31

Bank of America Corp DE reduced its holdings in shares of LivaNova PLC (NASDAQ:LIVN – Get Rating) by 0.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 618,145 shares of the company's stock after selling 2,059 shares during the quarter. Bank of America Corp DE owned 1.16% of LivaNova worth $50,582,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Sumitomo Mitsui Trust Holdings Inc. purchased a new position in shares of LivaNova in the first quarter valued at $64,579,000. P2 Capital Partners LLC bought a new position in LivaNova during the 4th quarter valued at $56,968,000. Goldman Sachs Group Inc. raised its holdings in shares of LivaNova by 63.0% during the first quarter. Goldman Sachs Group Inc. now owns 993,066 shares of the company's stock worth $81,263,000 after purchasing an additional 383,973 shares during the period. Marshall Wace LLP raised its holdings in shares of LivaNova by 397.7% during the fourth quarter. Marshall Wace LLP now owns 461,729 shares of the company's stock worth $40,370,000 after purchasing an additional 368,955 shares during the period. Finally, Greenlight Capital Inc. raised its holdings in shares of LivaNova by 92.1% during the fourth quarter. Greenlight Capital Inc. now owns 341,000 shares of the company's stock worth $29,814,000 after purchasing an additional 163,500 shares during the period. 98.89% of the stock is currently owned by hedge funds and other institutional investors.

Get LivaNova alerts:

Analyst Upgrades and Downgrades

A number of analysts have weighed in on LIVN shares. Needham & Company LLC dropped their target price on shares of LivaNova from $106.00 to $88.00 and set a "buy" rating on the stock in a report on Thursday, August 4th. StockNews.com raised shares of LivaNova from a "hold" rating to a "buy" rating in a report on Friday, September 9th. Finally, The Goldman Sachs Group dropped their price objective on shares of LivaNova from $85.00 to $73.00 and set a "buy" rating on the stock in a report on Tuesday, August 16th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average target price of $90.20.

LivaNova Stock Down 0.9 %

LivaNova stock opened at $50.01 on Wednesday. The stock has a market cap of $2.67 billion, a price-to-earnings ratio of -89.30 and a beta of 0.91. The company has a current ratio of 2.93, a quick ratio of 2.47 and a debt-to-equity ratio of 0.36. The company's 50-day moving average price is $59.38 and its two-hundred day moving average price is $66.76. LivaNova PLC has a 52 week low of $47.55 and a 52 week high of $93.89.

LivaNova (NASDAQ:LIVN – Get Rating) last announced its earnings results on Wednesday, August 3rd. The company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.51 by $0.02. The company had revenue of $254.20 million during the quarter, compared to analysts' expectations of $249.55 million. LivaNova had a negative net margin of 2.74% and a positive return on equity of 9.35%. The business's revenue for the quarter was down 3.9% on a year-over-year basis. During the same period last year, the company posted $0.52 earnings per share. On average, analysts expect that LivaNova PLC will post 1.91 EPS for the current fiscal year.

About LivaNova

(Get Rating)

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.

Read More

  • Get a free copy of the StockNews.com research report on LivaNova (LIVN)
  • Defensive Stocks For A Volatile Market
  • SunPower Is Ready To Power Up Triple-Digit Earnings Gains
  • Will UPS Be Next to Deliver a Warning?
  • Is This the Darkest Before the Dawn for Gap Stock?
  • Build A Better Tech Portfolio With Jabil Inc.

Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN – Get Rating).

Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment